Thursday November 26 2009 | Biotechnology feed | All feeds
|
|
U3 Pharma AG
Download detailed PDF Members: U3 Pharma AG is an emerging leader in targeted cancer drug development. The company has produced a pipeline of novel targeted therapeutics based on the ground-breaking discoveries made by its founder - Prof. Axel Ullrich.U3 Pharma´s vision is to provide clinical oncologists with an arsenal of new targeted therapeutics that can be employed to turn cancer. an often life threatening disease, into a chronic, non-life threatening condition. U3 Pharma's two lead programs each focus on fully human antibodies that are in co-development with Amgen, and are nearing the clinic as potential therapies for breast, lung and colorectal cancers, among others.
This page has been viewed 408 times since April 2007, the link to the organisation's website has been followed 79 times Recent Search Terms used to find this page: u3 pharma | u3 pharma | U3 Pharma AG | u3 pharma technology | U3 Pharma Ag | U3 PHARMA | u3 pharma | u3 pharma | u3 pharma | u3 pharma email | . Search for more companies in Martinsried This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for U3 Pharma AG | ||||||||||||||||||||||||||||||||||
|